Duality Advisers’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-11,823
| Closed | -$611K | – | 548 |
|
|
2022
Q4 | $611K | Sell |
11,823
-26,234
| -69% | -$1.36M | 0.07% | 405 |
|
|
2022
Q3 | $2.6M | Buy |
+38,057
| New | +$2.6M | 0.28% | 135 |
|
|
2021
Q4 | – | Sell |
-111,100
| Closed | -$3.66M | – | 488 |
|
|
2021
Q3 | $3.66M | Buy |
+111,100
| New | +$3.66M | 0.28% | 139 |
|
|
2021
Q2 | – | Sell |
-15,188
| Closed | -$652K | – | 525 |
|
|
2021
Q1 | $652K | Buy |
+15,188
| New | +$652K | 0.06% | 412 |
|
|
2020
Q4 | – | Sell |
-8,800
| Closed | -$265K | – | 546 |
|
|
2020
Q3 | $265K | Buy |
+8,800
| New | +$265K | 0.02% | 537 |
|